[ad_1]
In new hope for cancer patients, a recent US study confirmed that a recently approved drug has proven very effective in the treatment of one type of leukemia.B–cell ltheremphoma).
And paid Researchers at the MD Anderson Cancer Center at the University of Texas, United States Study to discover the real medicine (AxI–cel), Which was approved by the US Food and Drug Administration in October 2017 and by the European Commission in August 2018 for the treatment of lymphoma.
The researchers found that 83% of patients achieved a reduction in cancer-related activity, called objective response, while the full response rate of treatment was 58%.
The new main treatment idea is to extract the immune cells from the patient's body and reconfigure their genes so that they only attack the tumor, then return them to the body to do the work and remove the tumor. Cancer.
Source link
